This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Biohaven (NYSE:BHVN), Avient (NYSE:AVNT)

Group 1 - KeyBanc analyst Aleksey Yefremov initiated coverage on Avient Corporation (AVNT) with an Overweight rating and a price target of $48, while shares closed at $35.77 [5] - Barclays analyst Etzer Darout initiated coverage on Protagonist Therapeutics, Inc. (PTGX) with an Overweight rating and a price target of $72, with shares closing at $58.59 [5] - Citigroup analyst Samantha Semenkow initiated coverage on Biohaven Ltd. (BHVN) with a Buy rating and a price target of $28, while shares closed at $13.49 [5] - Barclays analyst Etzer Darout also initiated coverage on Summit Therapeutics Inc. (SMMT) with an Underweight rating and a price target of $13, with shares closing at $18.12 [5] - Bernstein analyst Zhihan Ma initiated coverage on Five Below, Inc. (FIVE) with a Market Perform rating and a price target of $160, while shares closed at $149.06 [5]